EAPO President Grigory Ivliev took part in the discussion “IP in Pharmaceuticals: Continuing the Dialogue,” attended by the representatives of Russian and foreign pharmaceutical companies and state authorities.
The key topics for discussion were:
- strengthening the protection of patent rights to medicines,
- the practice of issuing compulsory licenses,
- ensuring a balance of interests when promoting the manufacturing pharmacies,
- the relevance of uniform approaches in the decisions of federal executive authorities and courts.
The participants acknowledged the importance of the Eurasian Pharmaceutical Register for quick access to data on patent status and prevention of infringement.
The EAPO is discussing the possibility of concluding agreements with the EAPO member states, which would allow to determine the legal status of data from the Eurasian Pharmaceutical Register and use it as official in law enforcement practice.
“IP is not a barrier to available medicines but a tool to encourage the production of new medicines and competition for the market. Those who offer more effective methods of treatment should win,” Grigory Ivliev noted.
You can find the necessary information and video of the session here
Photo: Roscongress
